Francois Cedric Insider Profile

Francois Cedric, CEO, Director at Apellis Pharmaceuticals, holds 1.81M shares in Apellis Pharmaceuticals (Ticker: APLS).
Francois Cedric

Francois Cedric
Apellis Pharmaceuticals (APLS)
CEO, Director

Ranked #23,136 out of 103,103 Corporate Insiders

Profitable Transactions

3 out of 7 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Francois Cedric's holdings

Insider Roles

Apellis Pharmaceuticals
CEO, Director
Roles that Francois Cedric holds in companies

Most Profitable Insider Trade

Apellis Pharmaceuticals
Rating:Informative Buy
Date:Jul 01, 2019 - Jul 01, 2020
The most profitable trade made by Francois Cedric

Francois Cedric's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Apellis Pharmaceuticals
Mar 23, 2023
CEO, Director
Uninformative Sell
Success Rate for APLS
3 out of 7 profitable transactions on APLS
Average Return for APLS
Average return per transaction on APLS
No. of Shares
Price per Share
Link to Report
May 09, 2018
Uninformative Buy
Jul 01, 2019
Informative Buy
Aug 26, 2019
Informative Buy
Feb 12, 2020
Uninformative Buy
Dec 02, 2020
Informative Buy
List of latest transactions for each holding click on a transaction to see Francois Cedric's performance on stock

Francois Cedric insider profile FAQ

What is the percentage of profitable transactions made by Francois Cedric?
The percentage of profitable transactions made by Francois Cedric is 43%.
    What is the average return per transaction made by Francois Cedric?
    The average return per transaction made by Francois Cedric is 11.60%.
      What stocks does Francois Cedric hold?
      Francois Cedric holds: APLS stocks.
        What was Francois Cedric’s latest transaction?
        Francois Cedric latest transaction was an Uninformative Sell of $1.88M.
          What was Francois Cedric's most profitable transaction?
          Francois Cedric’s most profitable transaction was an Informative Buy of APLS stock on July 1, 2019. The return on the trade was 59.20%.
            What is Francois Cedric's role in Apellis Pharmaceuticals?
            Francois Cedric's role in Apellis Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.